Skip to content

Investor Centre

Information about our corporate activities for current shareholders and potential investors.

PharmX Technologies Limited is an Australian-owned, publicly listed company. PharmX Technologies shares are listed on the Australian Securities Exchange (ASX) and are traded under the code PHX. The company’s financial year runs from 1 July to 30 June, with half-year results announced in February and the full year results announced in August each year.

Announcements

Notification regarding unquoted securities – PHX
March 1, 2024
Half Yearly Report and Accounts
February 23, 2024
Results Release and Investor Presentation
February 23, 2024
Appointment of Interim CFO and change of Company Secretary
February 22, 2024
Change of Director’s Interest Notice – N England
February 16, 2024
Notice of Results Announcement
February 14, 2024
Response to ASX Price Query
February 12, 2024
Capital Return Confirmation
December 5, 2023
Return of Capital – PHX
November 22, 2023
Chair’s Address to Shareholders
November 21, 2023
Results of Meeting
November 21, 2023
Appointment of Chief Executive Officer
November 15, 2023
Notice of Annual General Meeting/Proxy Form
October 20, 2023
Notification of cessation of securities – PHX
October 17, 2023
Application for quotation of securities – PHX
October 16, 2023
Change of Company Name
October 4, 2023
Completion of sale of pharmacy software business
October 2, 2023
Results of General Meeting
September 20, 2023
Appendix 4G and Corporate Governance Statement
August 23, 2023
FY23 Appendix 4E and Annual Report
August 23, 2023
FY23 Results Announcement
August 23, 2023
FY23 Results Investor Presentation
August 23, 2023
Notice of Extraordinary General MeetingProxy Form
August 18, 2023
Loading

Corporate Governance

Corporate Governance Statement 2023
Corporate Code of Conduct
Board Charter
Anti-Bribery and Corruption Policy
Notice of Rights of Members in connection with certain documents – Corporations Act 2001 S110K
Company Constitution
Remuneration and Nomination Committee Charter
Audit and Risk Committee Charter
Conflict of Interest Policy
Diversity and Inclusion Policy
Corporate Security Trading Policy
Market Disclosure Policy
Whistleblower Policy
Omnibus Equity Plan Rules

Annual Reports

2023 Annual Report
2022 Annual Report
2021 Annual Report
2020 Annual Report
2019 Annual Report
2018 Annual Report
Loading